← Leaderboards
Jason D. Morrow
Vanderbilt University
$8,525,350
Attributed
$8,525,350
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$18,006,478 · 10
By mechanism
P50$10,778,949 · 4
P01$4,062,875 · 3
R01$1,924,377 · 1
T32$1,214,026 · 1
M01$26,251 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- L Jackson Roberts$17,065,377
- Thomas J Montine$57,372,903
- Falck John Russell$975,684
- Loren Keith Henry$1,535,472
- F Peter Guengerich$48,178,939
Others in their field
Top investigators on “Eicosanoids”
- Kafait U Malik · University Of Tennessee Health Sci Ctr$16,505,988
- Charles Nicholas Serhan · Brigham And Women'S Hospital$16,386,968
- Richard W Gross · Washington University$16,041,110
- Joshua A Boyce · Brigham And Women'S Hospital$14,653,598
- Susan Cheng · Brigham And Women'S Hospital$14,432,722
- Michal Laniado Schwartzman · New York Medical College$13,417,984
Research focus
EicosanoidsPharmacologyEicosanoid MetabolismProstaglandinsProstaglandin AnalogsOxidationArachidonatePropertyDocosahexaenoic AcidsPeroxidationDioxolanesPathway InteractionsPeroxidesMediatingGenerationsIn VivoFormal GlycolComplexInsightHuman SubjectIsoprostanesFree RadicalsIn VitroOxygen
Grant awards (44)
Project 2: Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$308,502
P01 · FY2012 · ES · contact PI
Project 2: Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$303,995
P01 · FY2011 · ES · contact PI
Project 2: Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$307,438
P01 · FY2010 · ES · contact PI
HUMAN PHARMACOLOGY OF DOCOSAHEXAENOIC ACID OXIDATION$264,411
P50 · FY2010 · GM · contact PI
Project 2: Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$303,244
P01 · FY2009 · ES · contact PI
HUMAN PHARMACOLOGY OF DOCOSAHEXAENOIC ACID OXIDATION$261,522
P50 · FY2009 · GM · contact PI
Project 2: Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$294,741
P01 · FY2008 · ES · contact PI
HUMAN PHARMACOLOGY OF DOCOSAHEXAENOIC ACID OXIDATION$253,836
P50 · FY2008 · GM · contact PI
Research Center for Pharmacology and Drug Toxicology$1,520,012
P50 · FY2007 · GM · contact PI
Clinical Pharmacology Training Program$371,998
T32 · FY2007 · GM · contact PI
Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$311,730
P01 · FY2007 · ES · contact PI
Biochemistry and Pharmacology of D2/E2 Isoprostanes$302,817
R01 · FY2007 · DK · contact PI
HUMAN PHARMACOLOGY OF DOCOSAHEXAENOIC ACID OXIDATION$282,021
P50 · FY2007 · GM · contact PI
Research Center for Pharmacology and Drug Toxicology$1,738,501
P50 · FY2006 · GM · contact PI
Clinical Pharmacology Training Program$351,417
T32 · FY2006 · GM · contact PI
Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$334,564
P01 · FY2006 · ES · contact PI
Biochemistry and Pharmacology of D2/E2 Isoprostanes$296,998
R01 · FY2006 · DK · contact PI
HUMAN PHARMACOLOGY OF DOCOSAHEXAENOIC ACID OXIDATION$175,562
P50 · FY2006 · GM · contact PI
ADMINISTRATIVE CORE$60,469
P50 · FY2006 · GM · contact PI
Research Center for Pharmacology and Drug Toxicology$1,263,595
P50 · FY2005 · GM
Biochemical Pharmacology of Eicosapentaenoic Acid Oxidation$344,413
P01 · FY2005 · ES
Biochemistry and Pharmacology of D2/E2 Isoprostanes$311,806
R01 · FY2005 · DK
Clinical Pharmacology Training Program$110,176
T32 · FY2005 · GM
PGE METABOLITE AND SELECTIVE COX INHIBITION$26,251
M01 · FY2005 · RR
Research Center for Pharmacology and Drug Toxicology$1,230,188
P50 · FY2004 · GM
Clinical Pharmacology Training Program$380,435
T32 · FY2004 · GM
Biochemistry and Pharmacology of D2/E2 Isoprostanes$319,365
R01 · FY2004 · DK
Research Center for Pharmacology and Drug Toxicology$1,220,488
P50 · FY2003 · GM
BIOCHEMISTRY AND PHARMACOLOGY OF D2/E2 ISOPROSTANES$181,162
R01 · FY2003 · DK
Research Center for Pharmacology and Drug Toxicology$1,202,341
P50 · FY2002 · GM
Cyclopentenone Prostaglandins and Colon Cancer$197,079
P01 · FY2002 · CA
Core--Eicosanoid Analysis$197,079
P01 · FY2002 · CA
BIOCHEMISTRY AND PHARMACOLOGY OF D2/E2 ISOPROSTANES$176,086
R01 · FY2002 · DK
Pharmacology of Cholesteryl Arachidonate Oxygenation$0
P50 · FY2002 · GM
Research Center for Pharmacology and Drug Toxicology$1,306,003
P50 · FY2001 · GM
Core--Eicosanoid Analysis$197,079
P01 · FY2001 · CA
Cyclopentenone Prostaglandins and Colon Cancer$197,079
P01 · FY2001 · CA
BIOCHEMISTRY AND PHARMACOLOGY OF D2/E2 ISOPROSTANES$171,072
R01 · FY2001 · DK
Pharmacology of Cholesteryl Arachidonate Oxygenation$0
P50 · FY2001 · GM
Cyclopentenone Prostaglandins and Colon Cancer$197,079
P01 · FY2000 · CA
Core--Eicosanoid Analysis$197,079
P01 · FY2000 · CA
Core--Eicosanoid Analysis$185,887
P01 · FY2000 · CA
Cyclopentenone Prostaglandins and Colon Cancer$185,887
P01 · FY2000 · CA
BIOCHEMISTRY AND PHARMACOLOGY OF D2/E2 ISOPROSTANES$165,071
R01 · FY2000 · DK